The prevalence of tuberculosis continues to be high, and nontuberculous mycobacterial (NTM) infection has also emerged worldwide. Moreover, differential and accurate identification of mycobacteria to the species or subspecies level is an unmet clinical need. Here, we developed a one-step multiplex PCR assay using whole-genome analysis and bioinformatics to identify novel molecular targets. The aims of this assay were to (i) discriminate between the Mycobacterium tuberculosis complex (MTBC) and NTM using rv0577 or RD750, (ii) differentiate M. tuberculosis (M. tuberculosis) from MTBC using RD9, (iii) selectively identify the widespread M. tuberculosis Beijing genotype by targeting mtbk_20680, and (iv) simultaneously detect five clinically important NTM (M. avium, M. intracellulare, M. abscessus, M. massiliense, and M. kansasii) by targeting IS1311, DT1, mass_3210, and mkan_rs12360. An initial evaluation of the multiplex PCR assay using reference strains demonstrated 100% specificity for the targeted Mycobacterium species. Analytical sensitivity ranged from 1 to 10 pg for extracted DNA and was 10 3 and 10 4 CFU for pure cultures and nonhomogenized artificial sputum cultures, respectively, of the targeted species. The accuracy of the multiplex PCR assay was further evaluated using 55 reference strains and 94 mycobacterial clinical isolates. Spoligotyping, multilocus sequence analysis, and a commercial real-time PCR assay were employed as standard assays to evaluate the multiplex PCR assay with clinical M. tuberculosis and NTM isolates. The PCR assay displayed 100% identification agreement with the standard assays. Our multiplex PCR assay is a simple, convenient, and reliable technique for differential identification of MTBC, M. tuberculosis, M. tuberculosis Beijing genotype, and major NTM species.
specific primer sets, including the panmycobacterial 16S rRNA gene set and the sets for rv0577, RD9, IS1311, DT1, and mkan_rs12360, were constructed based on previous publications and reference sequences obtained from NCBI (http://www.ncbi.nlm.nih .gov/), followed by bioinformatics analysis as described in Materials and Methods.
16S rRNA gene (for detection of all mycobacteria). For pandetection of the genus Mycobacterium, we selected a consensus nonpolymorphic region of the 16S rRNA gene from six target mycobacterial species or subspecies (M. tuberculosis, M. avium, M. intracellulare, M. abscessus, M. massiliense, and M. kansasii) (15) . This consensus region can be used as a positive control when testing for the presence of mycobacteria with the multiplex PCR. a All primers were newly designed for this study, with the exception of the RD9 primer pair (17) . b Primer sets 1 to 8 were used for the first multiplex PCR assay; set 9 was used in the second multiplex PCR assay for optimization of CAS detection.
rv0577 (for discrimination of MTBC from NTM). IS6110, a marker commonly used to define MTBC, was reported to be absent from some M. tuberculosis strains and to be present in some NTM strains (16) . Therefore, rv0577 was chosen as the genotypic maker for the MTBC. rv0577 is an MTBC-restricted gene and was thus used to discriminate MTBC from NTM species (15) .
RD9 (for identification of M. tuberculosis in MTBC)
. RD9 corresponds to the intergenic region between rv2072c and rv2073c. This sequence is unique to M. tuberculosis and is absent from all other MTBC members (except for M. canettii) and from NTM species. Thus, selective amplification of this region is considered to be indicative of M. tuberculosis (17) .
mtbk_20680 (for identification of strains of the Beijing family of M. tuberculosis). Based on a comparative genomic analysis of M. tuberculosis K (M. tuberculosis Beijing family) and H37Rv (M. tuberculosis non-Beijing family), five M. tuberculosis K-specific gene clusters were identified (data not shown). One of these regions was completely conserved in all reference strains of the M. tuberculosis Beijing family but was absent from M. tuberculosis non-Beijing family strains. This region, which corresponds to mtbk_20620 to mtbk_20700 (Fig. 1A) , contains nine genes, including the proline-glutamic acid family gene mtbk_20640, encoding a mycobacterium-specific virulence factor, the tuf gene mtbk_20680, encoding the iron-regulated elongation factor Tu, and genes encoding various hypothetical proteins. Based on an alignment of all M. tuberculosis Beijing clinical isolate genome sequences, a section of mtbk_20680, which was the most highly conserved sequence without polymorphisms in this region, was selected as the specific molecular target to identify the M. tuberculosis Beijing family.
IS1311 and DT1 (for identification of M. avium and M. intracellulare). IS1311 and DT1 are insertion elements harboring transposase genes in M. avium and M. intracellulare, respectively. Although insertion elements can be unstable, IS1311 and DT1 are consistently associated with M. avium and M. intracellulare (18) . Thus, selective amplification of these regions is considered to indicate M. avium and M. intracellulare, respectively, although some exceptions exist.
mass_3210 (for identification of M. abscessus and M. massiliense). Using wholegenome sequence analysis, we previously discovered specific genes that potentially discriminate between MABC species (19) . Among these specific genes, mass_3210 (879 bp) is specific to M. massiliense and is located between mass_3209 and mass_3211, which correspond to mab_3265c and mab_3266c, respectively, in the M. abscessus genome. This insertion gene region can be used to differentiate M. abscessus from M. massiliense by designing primers to sites flanking mass_3210, i.e., to positions in mab_3265c/mass_3209 and mab_3266c/mass_3211 (Fig. 1B) .
mkan_rs12360 (for identification of M. kansasii). Before the whole-genome sequence of M. kansasii was published, p6123 was used as a specific DNA probe to identify M. kansasii. In addition, this sequence has also been used as a marker to detect the major types I and II of M. kansasii, which cause human disease (20) . The alignment analysis in our current study revealed that the M. kansasii-specific sequence cloned into p6123 corresponds to the mkan_rs12360 region. Thus, in this study, the M. kansasiispecific primers were designed based on the most highly conserved sequence without polymorphisms in mkan_rs12360.
Multiplex PCR design and interpretation. The assay utilizes an eight-target multiplex PCR, and the presence of specific amplicons is readily visualized on 6% acrylamide gels. The sizes of the resulting PCR products and the groups that they identify are as follows: a 506-bp amplicon specific to the 16S rRNA gene for all mycobacteria; a 705-bp amplicon specific to rv0577 for MTBC species; a 369-bp amplicon specific to RD9 for M. tuberculosis; a 231-bp amplicon specific to mtbk_20680 for the M. tuberculosis Beijing family; a 600-bp amplicon specific to IS1311 for MAC; a 106-bp amplicon specific to DT1 for M. intracellulare; a 310-bp amplicon and a 1,145-bp amplicon specific to mass_3210 for M. abscessus and M. massiliense, respectively; and a 199-bp amplicon specific to mkan_rs12360 for M. kansasii (Table 1) . For preliminary testing of the multiplex PCR, we included the eight main Mycobacterium species and also used one NTM species (M. fortuitum) and one nonmycobacterial species (Escherichia coli) as negative controls. No nonspecific amplification bands were seen in any of the multiplex PCR products, and the assay correctly identified the reference strains, as shown in Fig.  S1 and Table S1 in the supplemental material.
Development and evaluation of the first multiplex PCR assay. We evaluated a total of 108 strains, comprising 64 clinical isolates (39 M. tuberculosis and 25 NTM) ( Table 2 ) and 44 reference strains (9 MTBC, 34 NTM, and 1 nonmycobacterial species) ( (Table S2) , the MTB067 and 0A077 isolates belong to the M. tuberculosis Central Asia strain (CAS) lineage (lineage 3), which is a non-Beijing family of M. tuberculosis. However, they were misidentified as members of the M. tuberculosis Beijing family (lineage 2 of M. tuberculosis) by displaying the positive amplicon for mtbk_20680 in the initial design of our multiplex PCR assay. The M. tuberculosis Beijing genotype and CAS family are major lineages in Asian countries but occupy different geographical locations (21) . In addition, they are closer on the nucleotide level than other M. tuberculosis lineages when analyzed by spoligotyping. When using spoligotype-based lineage identification, M. tuberculosis Beijing family isolates are sometimes classified as belonging to M. tuberculosis CAS (10, 22, 23) . Although we wanted to increase the number of isolates to better evaluate the potential of our assay to discriminate between M. tuberculosis CAS and M. tuberculosis Beijing family strains in clinical isolates, we could not obtain more CAS isolates.
The 108 clinical and reference strains were correctly identified at the lineage and species levels with our multiplex PCR assay, except for the two strains described above. The assay demonstrated 100% sensitivity and 94.8% specificity for M. tuberculosis. In addition, the assay yielded 100% sensitivity and 100% specificity for MTBC and NTM.
Optimization of the multiplex PCR assay. Based on our in silico analysis system, the CAS/NITR 204 strain, which was used as a reference strain for the M. tuberculosis CAS To identify M. tuberculosis CAS exceptions, we replaced the rv0577 primer pair with another one that could discriminate between MTBC and NTM and could also distinguish M. tuberculosis CAS from other M. tuberculosis lineages. The target gene region was RD750 (rv1519-rv1520), which is an M. tuberculosis CAS-specific deletion (21) . The predicted PCR product size was 865 bp (primer set 9 in Table 1 ). Optimization results for the multiplex PCR assay are shown in Fig. 2 and Table 4 . We compared clinical M. tuberculosis isolate results of the first multiplex PCR with those of the second multiplex PCR ( If a sample yielded amplicons of 506 bp (16S rRNA gene) and 369 bp (RD9) in the optimized PCR assay, we concluded that the isolate was of the M. tuberculosis CAS lineage because, as with CAS/NITR 204, it lacked the M. tuberculosis Beijing familyspecific region. With the exception of rv0577, the compositions of the first and second primer sets for detecting NTM were exactly the same, so the band pattern and product sizes were also the same (Fig. 3B) . In addition, we tested the specificity of our primers for mycobacterial 16S rRNA against 10 nonmycobacterial species (12 strains), and none of the tested bacteria produced detectable amplicons in the multiplex PCR (Table 3 ). This optimization assay demonstrated 100% sensitivity and 100% specificity for M. tuberculosis. In addition, the assay yielded 100% sensitivity and 100% specificity for both MTBC and NTM. Next, we examined the limit of detection for the optimized multiplex PCR using serially diluted DNA from the targeted Mycobacterium spp. (Fig. 4) . The analytical sensitivity of the PCR ranged from 1 to 10 pg for all tested Mycobacterium spp., which is considered to be approximately equivalent to 10 3 to 10 4 CFU of mycobacteria (Fig. 4) .
Evaluation of the optimized multiplex PCR for clinical applicability. We further investigated whether the multiplex PCR assay can be employed in a clinical setting by using a predetermined number of isolates of the targeted Mycobacterium spp. The sensitivity of the multiplex PCR using DNA directly extracted from 10 2 to 10 7 mycobacteria was compared with that using DNA extracted from the same number of mycobacteria mixed with nonhomogenized artificial sputum samples (Fig. 5) . Consistent with the results of analytical sensitivity (Fig. 4) , DNA directly extracted from 10 3 to 
a RD750 was used in place of rv0577 to discriminate between the CAS and Beijing family (see Fig. S1 and S2 in the supplemental material). b Two clinical isolate exceptions (CAS) in the first multiplex PCR assay. c M. fortuitum was used as the representative template for another NTM species. 10 4 mycobacterial cells in pure culture was detectable, whereas 10-fold more mycobacteria (ranging from 10 4 to 10 5 ) were required for the multiplex PCR detection with nonhomogenized artificial sputum samples (Fig. 5) . Next, in a blinded manner, we clinically evaluated the assay using 30 sputum sample cultures grown in mycobacteria growth indicator tubes (MGIT) by comparing the results with those obtained with a commercial real-time PCR assay. The multiplex PCR showed 100% identification agreement with the commercial assay (Fig. 6) . Next, we investigated whether the multiplex PCR assay could accurately identify M. tuberculosis in the presence of NTM, an important consideration when TB patients are also infected with NTM. In this experiment, the amount of M. tuberculosis DNA was fixed to 100 pg and then mixed with 100-fold-lower to 100-foldgreater amounts of DNA from NTM species (see Fig. S3 in the supplemental material). Not only could the multiplex PCR assay differentially detect each Mycobacterium spp., but there was also no interference in detection, except when DNA from the M. tuberculosis Beijing strain was mixed with excess DNA from M. intracellulare (a Ͼ10-fold-greater amount) (Fig. S3) .
DISCUSSION
The development of a method for efficiently and differentially identifying MTBC and the major NTM organisms causing human disease has the potential to greatly aid the control of mycobacterial infections. Most importantly, the increased possibility for accurate and early identification of specific species or subspecies can improve patient management, decisions on therapeutic regimens, and public health. In the present study, we developed a simple and effective one-step multiplex PCR assay that enables the differential identification of medically important Mycobacterium species as well as subspecies/members of the major mycobacterial complexes, including MTBC, MAC, and MABC. The specific aims of the assay were to (i) detect all Mycobacterium species, (ii) differentiate between MTBC and NTM, (iii) differentiate between M. tuberculosis and MTBC, (iv) selectively identify the M. tuberculosis Beijing family among M. tuberculosis members, and (v) simultaneously identify five clinically important NTM species causing lung disease.
In clinical laboratories, various methods for identifying Mycobacterium species have been introduced over the past decades (25) . Biochemical tests and high-performance liquid chromatography have been surpassed by molecular techniques as the methods of choice for discriminating the species of this genus. Molecular techniques, including restriction fragment length polymorphism analysis, spoligotyping, variable-number tandem repeat assays, PCR-based assays, and whole-genome sequencing (26) , have been used to detect and identify mycobacterial species. These techniques reduce the turnaround time for the results to be reported, thereby enabling the acceleration of treatment decisions according to the etiologic species (26) (27) (28) (29) . Multiplex PCR assays for the identification of specific groups of mycobacteria, mainly MTBC and MAC, have been developed and evaluated (15, 17, 18, 29, 30) . However, although several multiplex PCR systems have already been commercialized and introduced into laboratories (30) (31) (32) , to the best of our knowledge, there are no one-step multiplex PCR assays capable of simultaneously discriminating various clinically important major Mycobacterium species. Moreover, established PCR assays also normally require two PCR steps to distinguish the mycobacterial isolates to the species and/or subspecies level (33, 34) .
In this study, we developed a new multiplex PCR assay that simultaneously targets major Mycobacterium species causing human disease and that has a broad detection range. Insertion or deletion regions specific to each species of Mycobacterium provided meaningful markers for their identification. All primers, except for RD9, were newly designed and optimized for development of the multiplex PCR assay in this study.
For verification of mycobacterial identification, amplification of the 16S rRNA gene served as an internal control (15) . Then, based on rv0577, we classified all tested mycobacteria as either MTBC or NTM. In general, rv0577 and IS6110 can be used to detect MTBC (15, 35) . However, although IS6110 can be distributed throughout the whole MTBC genome, some MTBC strains have few or no copies of this element (35) , and therefore rv0577 may be a more reliable target than IS6110. Another of our targets, RD9, can be used to differentiate M. tuberculosis from the other MTBC species (17) because it is missing from all MTBC species except M. tuberculosis. Our assay also includes primer sets for five target NTM genes: IS1311 for M. avium, DT1 for M. intracellulare, mass_3210 for M. abscessus and M. massiliense, and mkan_rs12360 for M. kansasii. In addition, mass_3210 was newly employed in this study, and all of the NTM-targeting primer sets have been used as reliable markers for their corresponding species. Lastly, mtbk_20680 is used to target the M. tuberculosis Beijing family.
The data presented here suggest several limitations of this multiplex PCR assay. First, two M. tuberculosis clinical isolates belonging to the CAS lineage were identified as belonging to the M. tuberculosis Beijing family by mtbk_20680 detection. Of note, the CAS lineage and Beijing family are much closer by single nucleotide polymorphism (SNP) type and spoligotyping than other lineages. For example, the M. tuberculosis CAS lineage belongs to principal genetic group 1 (PGG1) and cluster II, which includes the East-Africa-Indian and East-Asian lineages (21) . PGG1 strains usually share spacers 35 and 36, which are lacking in other strains, and the M. tuberculosis CAS lineage and M. tuberculosis Beijing family have many more overlapping SNPs than other lineages. Therefore, these lineages are sometimes classified into the same (or a similar) genotype family (21) . It has also been reported that pseudo-Beijing strains harbor the Beijing spoligotyping patterns, but these strains have smaller deletions in RD207 than those of true Beijing strains (36) . Since few genomic data have been published for the CAS lineage, we selected mtbk_20680 based on genomic analysis of CAS/NITR204 for lineage 3, which belongs to PGG1. Genome information for this lineage is available only among CAS lineages in the public databases. In addition, one CAS strain was allocated to the Beijing family when its whole-genome sequence was analyzed by average nucleotide identity (data not shown), whereas this strain demonstrated CAS patterns in spoligotyping assays. Thus, mtbk_20680 is uniquely conserved in the Beijing lineage and in CAS genetically close to the Beijing family; the mtbk_20680-associated cluster may be useful for understanding evolutionary processes and in epidemiological studies of the Beijing lineage and related genotypes.
A second limitation of our multiplex PCR assay is its inability to differentiate M. canettii from the M. tuberculosis Beijing family. However, although the multiplex PCR patterns were identical for M. canettii and the M. tuberculosis Beijing family (data not shown), M. canettii is extremely rare in human cases, with most cases found in the Horn of Africa, and it displays a distinct smooth morphotype (2) that can also be used to aid identification. M. canettii is considered a phylogenetic prototype of MTBC and evolutionally located outside the main subspecies of MTBC (2). For these reasons, clinical identification of M. canettii is ruled out occasionally when developing molecular diagnostic tests for Mycobacterium spp. (2, 37) .
Third, IS1311 and DT1 are reliably found in M. avium and M. intracellulare, respectively, with only one exception reported (18) . IS1311 alone may be not enough to classify all isolates to the MAC subspecies level. Although M. avium subsp. hominissuis is the major member of the MAC that infects humans, other MAC subspecies (including M. avium subsp. avium and M. avium subsp. paratuberculosis), which generally cause animal disease, can also cause human disease (18) . Recently, Kim et al. reported that although DT1 is thought to be specific to M. intracellulare, it has occasionally been observed in M. avium. Since this element is mobile by nature, it is possible to find this element in related or unrelated bacteria (38) . Thus, strains known to be exceptions should be tested using our multiplex PCR assay.
Fourth, M. massiliense and M. bolletii were recognized as the same species. However, M. bolletii was recently reported to have a taxonomic status independent from M. massiliense (39) . Although M. bolletii is an MABC that rarely causes human disease, it would be preferable if the multiplex PCR mixture contained a marker to discriminate these three subspecies within the MABC, including M. bolletii.
Fifth, mixed infection of M. tuberculosis and NTM is difficult to diagnose in clinical practice (40) . Our multiplex PCR assay has the advantage of being able to detect mixed-infection cases, including M. tuberculosis and NTM (see Fig. S3 in the supplemental material). However, it is difficult to discriminate coinfections with M. tuberculosis Beijing family and non-Beijing family species, since the multiplex PCR assay results are obtained by visual readout.
Sixth, for the initial evaluation on the optimized multiplex PCR assay, we used high-quality DNA manually prepared from carefully controlled cultures of each of the five clinical isolates of NTM species and subspecies and 64 MTBC (Fig. 3) . Although the multiplex PCR was able to identify MGIT cultures even after a crude DNA preparation method such as boiling (Fig. 6) , the analytical sensitivity of the assay to nonhomogenized artificial sputum samples was 10-fold lower than to purely cultured bacteria (Fig.  5) . Thus, further testing is required to determine its suitability for identifying species directly in acid-fast bacillus smear-positive respiratory specimens such as human sputum samples.
Nevertheless, additional advantages of our assay are that it requires only common PCR reagents, uses a simple method, and employs standard equipment; these features frequently underpin routine diagnostic tests in laboratories. In contrast, real-time PCR requires expensive equipment and reagents. In addition, our one-step multiplex PCR platform does not require an additional step (e.g., a nested-PCR platform). Thus, the assay reliability is relatively high compared to other assays, since sample contamination is reduced. In addition, the primer sets adopted in this study can be easily combined according to the targeted species and the study purpose. In conclusion, our one-step multiplex PCR platform is a convenient, cost-effective, and reliable method for detecting the most clinically important Mycobacterium species. The data provided from the multitarget PCR assay allow discrimination among major mycobacteria causing lung disease and improve diagnostic confidence in the identity of isolates. This assay will potentially improve the discrimination of clinical Mycobacterium isolates and also promises to be useful for the development of a routine method to be used in the clinical setting.
MATERIALS AND METHODS

Bacterial collection and identification of Mycobacterium species.
In this study, we tested 55 reference strains consisting of 8 MTBC strains (2 M. tuberculosis Beijing family strains, HN878 [41] and strain K [42] , 2 M. tuberculosis non-Beijing family strains, M. bovis strains, M. bovis BCG, M africanum, and M. microti), 34 NTM ATCC strains, and 12 nonmycobacterial strains (Table 3) . We also tested 94 clinical strains (48 M. tuberculosis and 46 NTM isolates) ( Table 2 ). Genotyping of the 39 M. tuberculosis and 9 M. tuberculosis clinical isolates was determined, respectively, by spoligotyping, which is a gold standard genotyping assay, and Advansure TB/NTM real-time PCR (LG Life Sciences, Daejeon, South Korea), a commercial kit used for diagnosis in laboratory medicine (4) . Spoligotyping of the 39 M. tuberculosis isolates was performed at Yonsei University (Wonju, South Korea), and real-time PCR of the 9 M. tuberculosis strains was performed at Yonsei University (Seoul, South Korea). In addition, the 25 NTM and 21 NTM clinical strains were identified by MLSA and Advansure TB/NTM real-time PCR at Samsung Medical Center (Seoul, South Korea) (19, (43) (44) (45) .
Bacterial cultures and DNA preparation. Mycobacterial culture was carried out as previously described (18) . Briefly, mycobacteria were cultivated in Middlebrook 7H9 liquid medium (pH 6.8; Difco Laboratories, Detroit, MI, USA) supplemented with 10% (vol/vol) oleic acid-albumin-dextrose-catalase (OADC; BD Diagnostics, Sparks, MD, USA) and incubated at 37°C or 30°C. Mycobacterial DNA from controlled cultures was extracted using the conventional cetyltrimethylammonium bromide method according to procedures previously described, with slight modifications (46) . DNA preparations from Bactec MGIT-960 tubes were performed using a Qiagen DNeasy blood & tissue kit (Qiagen, Inc., Valencia, CA, USA) or a simple boiling method (47) .
Identification of Mycobacterium species-specific target sequences and primer design. We employed two analytical strategies for the determination of targets and development of the multiplex PCR assay: (i) comparative genomic analysis of MTBC and MABC and (ii) bioinformatics analysis of M. avium, M. intracellulare, and M. kansasii based on previous studies and data available in the public domain via NCBI (http://www.ncbi.nlm.nih.gov/). Comparative genomic analysis was performed to find specific target sequences for the M. tuberculosis Beijing family and MABC strains. We selected M. tuberculosis K (GenBank accession no. CP007803.1) as the representative M. tuberculosis strain for the Beijing family (42) and M. abscessus (accession no. CU458896) and M. massiliense (accession no. NZ_JRMG00000000.1) as the representative MABC strains (19) . On alignment of the complete genomes of the K and H37Rv ATCC 27294 strains (accession no. NC_000962), several polymorphic sites that corresponded to single genes or insertion or deletion regions were found. The polymorphic regions were also compared with those of other strains of the Beijing family, including M. tuberculosis HN878, CCDC5079, CCDC5180, CTRI-4, 210, NCGM2209, R1207, and X122, and non-Beijing family strains, including EAI5/NITR206 for lineage 1, CAS/NITR204 for lineage 3, CDC1551 and F11 for lineage 4, ATCC 25420 for lineage 5, and GM 041182 for lineage 6, from previous publications and clinical isolates (24) .
For MABC-specific target sequences, the M. massiliense complete genome was compared with that of M. abscessus (19) , and several different regions were analyzed according to the steps described above. The other sequences (16S rRNA gene [15] , rv0577 [15] , RD9 [17] , IS1311, DT1 [18] , and mkan_rs12360 [20] ) were selected based on previous publications and bioinformatics analysis.
PCR primers were designed based on each target sequence, using the Vector NTI program (Thermo Fisher Scientific, MA, USA), and further analyzed to predict primer-dimer interactions when mixed in a multiplex PCR. Primer design for the 16S rRNA gene, rv0577 (15) , RD9 (rv2072c and rv2073c) (17) , and RD750 (rv1519 and rv1520) (15) amplicons was based on the M. tuberculosis H37Rv strain ATCC 27294. Primer pairs were designed based on the sequences of mtbk_20680 in M. tuberculosis strain K, IS1311 in M. avium (accession no. NC_008595), DT1 in M. intracellulare (accession no. NC_016946) (18) , and mkan_rs12360 in M. kansasii (accession no. NC_022663) (20) . mab_3265c in M. abscessus was formerly referred to as mass_3210, which is a single gene specific to M. massiliense. The M. abscessus and M. massiliense target primer pair was created using the region flanking mass_3210 (mab_3265c/mass_3209 to mab_3266c/mass_3211) ( Table 1) .
Multiplex PCR amplification and assay interpretation criteria. For amplification, each PCR mixture contained 25 l of 2ϫ EF-Taq PCR Smart mix (Solgent Co., Ltd. Daejeon, South Korea), 9.2 l of primer mix containing 4 l of the rv0577 primer set, 0.3 l of the DT1 and mtbk_20680 primer sets, and 1 l of the 16S rRNA, RD9, IS1311, mass_3210, and mkan_rs12360 primer sets (all primer solutions in 10 pmol), 2 l of DNA template, and 12.8 l of water in a final volume of 50 l. PCR amplification was performed in an S1000 Thermal cycler. Thermocycling parameters included an initial denaturation step at 95°C for 10 min, followed by 30 cycles of 96°C for 45 s, 61.5°C for 45 s, and 72°C for 40 s. The final extension step was performed at 72°C for 10 min. After amplification, PCR products were analyzed via acrylamide gel electrophoresis on 6% acrylamide gels and stained with 1 l of Gel Star (Lonza, Basel, Switzerland) in 50 ml of 1ϫ Tris-borate-EDTA (TBE) buffer. The assay products were electrophoresed for 37 min at 120 V in 1ϫ TBE buffer, and the gels were visualized under UV light.
The multiplex PCR interpretation criteria, which rely on deduction, and their target Mycobacterium species are listed in Table S1 . Simultaneous amplification of the four targets mtbk_20680, RD9, rv0577, and 16S rRNA gene was interpreted as association with the M. tuberculosis Beijing family; amplification of three targets excluding mtbk_20680 was interpreted as association with M. tuberculosis non-Beijing family species; and amplification of two targets excluding mtbk_20680 and RD9 was interpreted as association with MTBC. Amplification of IS1311, DT1, or mkan_rs12360 with the 16S rRNA gene was interpreted as identifying with M. avium, M. intracellulare, or M. kansasii, respectively, and amplification of mass_3210 with the 16S rRNA gene was interpreted as identifying with M. abscessus and M. massiliense. Mycobacterium species outside the multiplex PCR target species were indicated by observation of only 16S rRNA gene amplification.
Optimization of the multiplex PCR assay. The accuracy (specificity and sensitivity) of the multiplex PCR assay was evaluated using the 64 M. tuberculosis clinical isolates described above ( Table 2 ). The PCR products of all clinical strains were confirmed and compared with spoligotyping (Table S2) and MLSA results (NTM PCR results are shown in Fig. 3B ).
After the initial evaluation, rv0577 was replaced with RD750. Multiplex PCR optimization was then performed under the same PCR amplification conditions as described above, with the exception of the primer composition. Specifically, the primer mixture (7.6 l) consisted of 2 l of RD9, 1 l of DT1 and RD750, 0.8 l of 16S rRNA, IS1311, and mass_3210, and 0.6 l of the mtbk_20680 and mkan_rs12360 primer sets (Table 1) . with serial dilutions ranging from 100 ng to 0.01 pg per reaction mixture. After amplification, 4 l of the PCR mixture was loaded onto 6% acrylamide gels. The detection limit was determined to be the smallest DNA quantity that generated the correct band pattern for the targeted Mycobacterium spp.
Evaluation of the optimized multiplex PCR assay for clinical applicability. The multiplex PCR assay was evaluated using DNA extracted from nonhomogenized artificial sputum, generated as previously described (48) , that had been spiked with pure cultures of the targeted Mycobacterium spp. Mycobacterial DNA was prepared using a Qiagen kit as described above. Briefly, l ml of serial dilutions of the predetermined mycobacterial numbers was inoculated into 4 ml of 7H9-OADC broth and 4 ml of artificial sputum. The final CFU were adjusted to range from 10 to 10 8 CFU/sample for each tested Mycobacterium spp.
To assess applicability to coinfections of M. tuberculosis and NTM and possible interference in PCRs, the multiplex PCR was evaluated with mixed DNA from M. tuberculosis and each NTM species. Briefly, the amount of DNA from M. tuberculosis (HN878 for Beijing family and H37Rv for non-Beijing family) was fixed at 0.1 ng/reaction mixture, and DNA from each NTM species was added to the multiplex PCR mixture in increasing amounts to give M. tuberculosis DNA-to-NTM DNA ratios of 0.01 to 500.
Finally, the multiplex PCR was evaluated using DNA extracted from 9 M. tuberculosis and 21 NTM Bactec MGIT-960 cultures of patient sputa in a blinded manner. The identification results were compared with those obtained using AdvanSure TB/NTM real-time PCR. Since this real-time PCR kit is not able to discriminate between M. abscessus and M. massiliense, the presence of erm (41) was tested separately (19) .
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